Inhibitors of JAK-family kinases: an update on the patent literature 2013-2015, part 2
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inhibitors of JAK-family kinases: an update on the patent literature 2013-2015, part 2
Authors
Keywords
-
Journal
EXPERT OPINION ON THERAPEUTIC PATENTS
Volume 27, Issue 2, Pages 145-161
Publisher
Informa UK Limited
Online
2016-10-24
DOI
10.1080/13543776.2017.1252754
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inhibitors of JAK-family kinases: an update on the patent literature 2013-2015, part 1
- (2016) Jason G. Kettle et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial
- (2016) Sally Wenzel et al. LANCET
- Targeted anti-inflammatory therapeutics in asthma and chronic obstructive lung disease
- (2016) Andrew L. Durham et al. Translational Research
- Severe eosinophilic asthma treated with mepolizumab stratified by baseline eosinophil thresholds: a secondary analysis of the DREAM and MENSA studies
- (2016) Hector G Ortega et al. Lancet Respiratory Medicine
- The JAK-STAT Pathway: Impact on Human Disease and Therapeutic Intervention
- (2015) John J. O'Shea et al. Annual Review of Medicine
- Novel pyrrole carboxamide inhibitors of JAK2 as potential treatment of myeloproliferative disorders
- (2015) Maria Gabriella Brasca et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Epithelial cytokines and pulmonary allergic inflammation
- (2015) Clare M Lloyd et al. CURRENT OPINION IN IMMUNOLOGY
- Distinct endotypes of steroid-resistant asthma characterized by IL-17Ahigh and IFN-γhigh immunophenotypes: Potential benefits of calcitriol
- (2015) Emma S. Chambers et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- High IFN-γ and low SLPI mark severe asthma in mice and humans
- (2015) Mahesh Raundhal et al. JOURNAL OF CLINICAL INVESTIGATION
- Discovery of VX-509 (Decernotinib): A Potent and Selective Janus Kinase 3 Inhibitor for the Treatment of Autoimmune Diseases
- (2015) Luc J. Farmer et al. JOURNAL OF MEDICINAL CHEMISTRY
- Type I/II cytokines, JAKs and new strategies for treating autoimmune diseases
- (2015) Daniella M. Schwartz et al. Nature Reviews Rheumatology
- Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studies
- (2015) Nicola A Hanania et al. THORAX
- Rheumatoid arthritis response to treatment across IgG1 allotype – anti-TNF incompatibility: a case-only study
- (2015) Ariana Montes et al. ARTHRITIS RESEARCH & THERAPY
- Efficacy and safety of tralokinumab in patients with severe uncontrolled asthma: a randomised, double-blind, placebo-controlled, phase 2b trial
- (2015) Christopher E Brightling et al. Lancet Respiratory Medicine
- Selective inhibitors of the Janus kinase Jak3—Are they effective?
- (2014) Gebhard Thoma et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Effects of an Anti-TSLP Antibody on Allergen-Induced Asthmatic Responses
- (2014) Gail M. Gauvreau et al. NEW ENGLAND JOURNAL OF MEDICINE
- TSLP signaling pathway map: a platform for analysis of TSLP-mediated signaling
- (2014) J. Zhong et al. Database-The Journal of Biological Databases and Curation
- Benralizumab, an anti-interleukin 5 receptor α monoclonal antibody, versus placebo for uncontrolled eosinophilic asthma: a phase 2b randomised dose-ranging study
- (2014) Mario Castro et al. Lancet Respiratory Medicine
- Janus kinase inhibitors in autoimmune diseases
- (2013) John J O'Shea et al. ANNALS OF THE RHEUMATIC DISEASES
- Pyrrolopyrazines as Selective Spleen Tyrosine Kinase Inhibitors
- (2013) Fernando Padilla et al. JOURNAL OF MEDICINAL CHEMISTRY
- Dupilumab in Persistent Asthma with Elevated Eosinophil Levels
- (2013) Sally Wenzel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rhinovirus-induced interferon production is not deficient in well controlled asthma
- (2013) Annemarie Sykes et al. THORAX
- The interferon signature in autoimmune diseases
- (2012) Lars Rönnblom et al. CURRENT OPINION IN RHEUMATOLOGY
- Role of IL-6 in Asthma and Other Inflammatory Pulmonary Diseases
- (2012) Mercedes Rincon et al. International Journal of Biological Sciences
- Jak1 Has a Dominant Role over Jak3 in Signal Transduction through γc-Containing Cytokine Receptors
- (2011) Claude Haan et al. CHEMISTRY & BIOLOGY
- Lebrikizumab Treatment in Adults with Asthma
- (2011) Jonathan Corren et al. NEW ENGLAND JOURNAL OF MEDICINE
- Impaired type I and III interferon response to rhinovirus infection during pregnancy and asthma
- (2011) Rebecca Louise Forbes et al. THORAX
- Rapid Generation of a High Quality Lead for Transforming Growth Factor-β (TGF-β) Type I Receptor (ALK5)†
- (2009) Frederick W. Goldberg et al. JOURNAL OF MEDICINAL CHEMISTRY
- The JAK-3 inhibitor CP-690550 is a potent anti-inflammatory agent in a murine model of pulmonary eosinophilia
- (2008) Elizabeth Kudlacz et al. EUROPEAN JOURNAL OF PHARMACOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started